Evidence map›Paper›PMID 35862995›Full record

ArticleMicrobiology spectrum2022

Stenotrophomonas maltophilia from Nepal Producing Two Novel Antibiotic Inactivating Enzymes, a Class A β-Lactamase KBL-1 and an Aminoglycoside 6'-

Ryota Kawauchi, Tatsuya Tada, Jatan B Sherchan, Shovita Shrestha, Mari Tohya, Tomomi Hishinuma, Teruo Kirikae, Jeevan B Sherchand

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Antibiotics (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Comparative Analyses Suggest Genome Stability and Plasticity inInternational journal of molecular sciences · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ryota KawauchiDepartment of Microbiology, Juntendo Universitygrid.258269.2 Graduate School of Medicine, Tokyo, Japan.
Tatsuya TadaDepartment of Microbiology, Juntendo Universitygrid.258269.2 Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-3053-1879
Jatan B SherchanDepartment of Clinical Microbiology, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.
Shovita ShresthaDepartment of Microbiology, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.
Mari TohyaDepartment of Microbiology, Juntendo Universitygrid.258269.2 Graduate School of Medicine, Tokyo, Japan.
Tomomi HishinumaDepartment of Microbiology, Juntendo Universitygrid.258269.2 Graduate School of Medicine, Tokyo, Japan.
Teruo KirikaeDepartment of Microbiology, Juntendo Universitygrid.258269.2 Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0001-7114-769X
Jeevan B SherchandDepartment of Microbiology, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.
Juntendo University · JPTribhuvan University · NPKathmandu University · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seven drug-resistant strains of Stenotrophomonas maltophilia were isolated from patients at two university hospitals in Nepal. S. maltophilia JUNP497 was found to encode a novel class A β-lactamase, KBL-1 (Kathmandu β-lactamase), consisting of 286 amino acids with 52.98% identity to PSV-1. Escherichia coli transformants expressing

Indexed as

Stenotrophomonas maltophiliaAcetyltransferasesAmino AcidsAnti-Bacterial Agentsbeta-LactamasesEscherichia coliHumansMicrobial Sensitivity TestsNepalPenicillinsPhylogenyAcetyltransferasesAmino Acidsaminoglycoside N(6')-acetyltransferaseAnti-Bacterial Agentsbeta-LactamasesPenicillinsAAC(6′)-Iapdrug resistance mechanismsKBL-1Stenotrophomonas maltophilia

Identifiers

PMID35862995
PMCPMC9431274
OpenAlexW4284899226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.